| 标题 |
LBA112 Neoadjuvant gemcitabine intravesical system (TAR-200) + cetrelimab (CET) or CET alone in patients (pts) with muscle-invasive bladder cancer (MIBC): SunRISe-4 (SR-4) primary analysis and biomarker results |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:A. Necchi; F. Guerrero-Ramos; P.L. Crispen; B. Herrera Imbroda; R. Garje; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)